Cannabis Law Report
APRIL 8, 2022
Later that year, Doblin sued the DEA for the first time. submitted his first DEA application to manufacture marijuana for use in medical research. To celebrate this, we invite you to take a trip down memory lane and review highlights from every year of our history. Lyle Craker, Ph.D.,
Meadow
JULY 13, 2018
Back in 2007, it said we don’t want anymore cannabis businesses and despite a general prohibition, we still had more cannabis businesses than any other location. We’ve had a cap on that really since 2010 and one way or another, we’ve codified that now to a number of 30. It’s every square inch of it.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Cannabis Law Report
JULY 12, 2019
31) The United States DEA has stated that small amounts of other cannabinoids will also occur in all cannabis extracts, even those that purport to be CBD only – unless synthesized de novo, CBD isolate will always contain small amounts of THC when extracted from a plant. British Journal of Nutrition (2010), 104, 803–806. September 2004.
Cannabis Law Report
MARCH 25, 2019
The DEA has made previous requests–in 2001 and 2006–to the FDA for an evaluation of marijuana. But DEA regulators determined after both of those reviews that marijuana should remain a Schedule I substance. 3, 2010 , 124 Stat. 2003, 2004, 2007, 2008, Nov. 3, 2010 , 124 Stat. 109–248, title II , § ?
The Joint Blog
JUNE 2, 2020
In 2007, he acknowledged that ending raids on medical marijuana users was necessary, but that he believed that “there’s got to be a better answer than marijuana” for addressing health issues and symptoms. He voiced the long-debunked theory in 2010 that marijuana serves as a “gateway drug” to dangerous substances. Tulsi Gabbard Rep.
Expert insights. Personalized for you.
52 
Let's personalize your content